LOC100287944: A Drug Target / Disease Biomarker (G100287944)
LOC100287944: A Drug Target / Disease Biomarker
LOC100287944 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the LOC1002 family of proteins, which are known for their role in intracellular signaling.
One of the unique aspects of LOC100287944 is its expression pattern. It is highly expressed in the brain, where it is primarily found in the postsynaptic density of neurons. It is also expressed in other tissues, including the heart and kidneys, where it is involved in regulating various physiological processes.
The function of LOC100287944 is not well understood, but it is thought to play a role in intracellular signaling. It is involved in the regulation of various signaling pathways, including the TGF-β pathway and the Wnt pathway.
One of the most promising aspects of LOC100287944 is its potential as a drug target. Due to its involvement in intracellular signaling, LOC100287944 is a promising target for small molecules that can modulate signaling pathways.
In addition to its potential as a drug target, LOC100287944 is also a potential biomarker. Its highly expressed expression in the brain makes it an attractive candidate for use as a diagnostic or predictive marker for various neurological and psychiatric disorders.
Overall, LOC100287944 is a protein that is worth further research due to its potential as a drug target and biomarker. Further studies are needed to fully understand its function and its potential as a therapeutic agent.
Protein Name: Uncharacterized LOC100287944
The "LOC100287944 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100287944 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC100288069 | LOC100288162 | LOC100288208 | LOC100288637 | LOC100288656 | LOC100289230 | LOC100289283 | LOC100289308 | LOC100289333 | LOC100289361 | LOC100289470 | LOC100289473 | LOC100289495 | LOC100289511 | LOC100289561 | LOC100289580 | LOC100289656 | LOC100293211 | LOC100294145 | LOC100335030 | LOC100419773 | LOC100420587 | LOC100421561 | LOC100505498 | LOC100505502 | LOC100505585 | LOC100505664 | LOC100505715 | LOC100505716 | LOC100505841 | LOC100505912 | LOC100505915 | LOC100505978 | LOC100506023 | LOC100506071 | LOC100506076 | LOC100506124 | LOC100506207 | LOC100506236 | LOC100506274 | LOC100506281 | LOC100506379 | LOC100506403 | LOC100506422 | LOC100506444 | LOC100506446 | LOC100506472 | LOC100506474 | LOC100506499 | LOC100506514 | LOC100506532 | LOC100506606 | LOC100506634 | LOC100506639 | LOC100506667 | LOC100506730 | LOC100506974 | LOC100507002 | LOC100507006 | LOC100507053 | LOC100507054 | LOC100507156 | LOC100507165 | LOC100507221 | LOC100507250 | LOC100507336 | LOC100507346 | LOC100507351 | LOC100507389 | LOC100507412 | LOC100507424 | LOC100507443 | LOC100507513 | LOC100507520 | LOC100507547 | LOC100507577 | LOC100507656 | LOC100509646 | LOC100533709 | LOC100630923 | LOC100652743 | LOC100652768 | LOC100652833 | LOC100652999 | LOC100653061 | LOC100996385 | LOC100996412 | LOC100996583 | LOC100996637 | LOC100996643 | LOC100996664 | LOC100996770 | LOC101060017 | LOC101060106 | LOC101060179 | LOC101060400 | LOC101060445 | LOC101060524 | LOC101060632 | LOC101448202
